Study suggests GLP-1 drugs could lower risk of 10 obesity-related cancers
A new study reported by Reuters suggests that GLP-1 receptor agonists, a widely used class of diabetes and weight-loss drugs, may be associated with a lower risk of developing 10 cancers tied to…

